Rights and permissions
About this article
Cite this article
Dalteparin cost effective for VTE prophylaxis in the US?. Pharmacoecon. Outcomes News 488, 4 (2005). https://doi.org/10.2165/00151234-200504880-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200504880-00007